Cefpirome
| Code | Size | Price |
|---|
| TAR-T4995L-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Cefpirome is a broad-spectrum, fourth-generation cephalosporin. It binds to and inactivates penicillin-binding proteins located on the inner membrane of the bacterial cell wall.
CAS:
84957-29-9
Formula:
C22H22N6O5S2
Molecular Weight:
514.58
Purity:
0.98
SMILES:
[H][C@]12SCC(C[n+]3cccc4CCCc34)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)c1csc(N)n1)C([O-])=O
References
Gon?alves-Pereira J, P?voa P. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of ?-lactams. Crit Care. 2011;15(5):R206. doi: 10.1186/cc10441. Epub 2011 Sep 13. Review. PubMed PMID: 21914174; PubMed Central PMCID: PMC3334750.
Livermore DM, Hope R, Mushtaq S, Warner M. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:189-93. Review. Erratum in: Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4. PubMed PMID: 18154546.
Deshayes S, Coquerel A, Verdon R. Neurological Adverse Effects Attributable to ?-Lactam Antibiotics: A Literature Review. Drug Saf. 2017 Dec;40(12):1171-1198. doi: 10.1007/s40264-017-0578-2. Review. PubMed PMID: 28755095.
Seral C, Gude MJ, Castillo FJ. [Emergence of plasmid mediated AmpC ?-lactamasas: Origin, importance, detection and therapeutical options]. Rev Esp Quimioter. 2012 Jun;25(2):89-99. Review. Spanish. PubMed PMID: 22707098.